Search Results - "Slager, Anna M."
-
1
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Published in The Lancet (British edition) (21-11-2015)“…Summary Background Despite preventive vaccines for oncogenic human papillomaviruses (HPVs), cervical intraepithelial neoplasia (CIN) is common, and current…”
Get full text
Journal Article -
2
Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells
Published in The Journal of molecular diagnostics : JMD (01-02-2006)“…Ulcerative colitis (UC) and Crohn's disease (CD) are common inflammatory bowel diseases producing intestinal inflammation and tissue damage. Although emerging…”
Get full text
Journal Article -
3
Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models
Published in Molecular therapy (06-02-2019)“…Ovarian cancer presents in 80% of patients as a metastatic disease, which confers it with dismal prognosis despite surgery and chemotherapy. However, it is an…”
Get full text
Journal Article -
4
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells
Published in Journal of translational medicine (16-10-2008)“…LXRs (Liver X Receptor alpha and beta) are nuclear receptors that act as ligand-activated transcription factors. LXR activation causes upregulation of genes…”
Get full text
Journal Article -
5
417. Induction of Potent Cytotoxic and Antitumor Activity By a Highly Optimized hTERT DNA Vaccine
Published in Molecular therapy (01-05-2015)Get full text
Journal Article